SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

BREAKING BOUNDARIES OF SCIENCE, TECHNOLOGY, MEDICINE, ART & HEALTHCARE POLICY

SBMT 2024 | Sponsors

Partnerships that advance us to the future

SBMT is thrilled to announce our esteemed sponsors for the 2024 Annual World Congress!

Their invaluable support enables us to curate a truly exceptional event, bringing together leading scientists, physicians, policymakers, and industry leaders from around the globe.

Through their collaboration, we can offer:

  • A world-class program: Featuring cutting-edge research, insightful presentations, and engaging discussions on groundbreaking advancements in brain mapping and therapeutics.
  • Unique networking opportunities: Creating a platform for exchanging ideas, and building  connections.
  • Increasing accessibility: Showcasing novel solutions poised to shape the future of brain mapping and therapeutic interventions.

As a sponsor, these organizations demonstrate their commitment to:

  • Advancing scientific research and discovery.
  • Improving patient care quality.
  • Propelling the next generation of leaders and innovators.

We encourage you to explore the profiles of our sponsors below and learn more about their dedication to shaping the future of brain health.

World Brain Mapping Foundation

Your Participation Changes Lives.

WBMF was established to facilitate multidisciplinary brain and spinal cord research and expedite the integration and translation of cutting-edge technologies into neuroscience while focusing on translating state-of-the-art technologies from Space and defense industries into neuroscience to bring the most advanced medicine to wounded warriors and civilians.

GFC Awards Gala

Mind-Eye Institute

Mind-Eye Institute

Our Mision

To transform the lives of millions of patients—children and adults—who suffer from lingering symptoms caused by brain injury, autism, learning disorders and neurodegenerative diseases by applying 21st century discoveries in neuroscience and neurophotonics to classic optometric eye care. This goal will be achieved through expansion of innovative clinical work using advanced technology and ongoing collaborative research and study. By synchronizing auditory and visual localization, 
a person’s reactions and responses to light and other environmental changes can be measured and modified to positively impact brain function and body chemistry.

The Z-Bell℠ Test

About Us

Applied Neuroscience, Inc. (ANI) was founded in 2001 and is currently registered in the State of Florida. ANI houses digital EEG data from over 20,000 subjects that was collected over the past 40 years. ANI also houses many MRIs and neuropsychological tests that have been correlated with EEG for both research and clinical validation studies resulting in over 200 publications and eight books. The staff of ANI has either supervised or written clinical reports on over 20,000 patients, including traumatic brain injured patients, ADD, ADHD, strokes, tumors, epilepsy, depression and other clinical conditions.

NeuroGuideTM

Actionable genetic insights for better patient care

Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform.

Through our diverse testing menu, Fulgent is focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike.

Since integrating with our therapeutic development business, Fulgent is also developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform. By merging our fields of expertise, we aim to become a fully integrated precision medicine company.

 

Request Kits

Why We Stand Out

It is our privilege to offer you an unconditional invitation to experience mental health care in a personalized, positive, and seamless fashion. In our practice, we provide advanced science and technology in a serene, spa-like environment to make your journey toward wellness effective and enjoyable.

Integrative Psychiatry
Cutting-Edge Technology
Good Karma

Mission

The mission of the Sunder Foundation is to connect art, science and people with the blossoming possibilities of mental wellness. By incorporating socio-cultural, artistic and technological innovations, we aim to facilitate a deep sharing, healing and honoring of our stories and selves. Through fostering connections with one another and with nature, we strive to develop a compassionate culture of understanding and celebration of diversity, that ultimately strengthens and nourishes the universal in all of us.

Karma TMS

Ukraine Humanitarian Mission

Data return wellbeing;

AIRS Medical is a healthcare AI company transforming inefficiencies in the medical industry through innovative technology, enabling more people to access healthcare. Flagship product SwiftMR™ is a transformative solution that reduces MRI scan times, enhancing patient comfort without sacrificing image quality. Developed with a cutting-edge deep learning model, SwiftMR™ is designed to integrate seamlessly with existing MRI systems.

 

With SwiftMR™ your practice can experience:

  • Enhanced Efficiency: Proven to reduce MRI scan times by up to 50%, significantly boosting patient throughput.
  • Exceptional Image Quality: Enhances image quality, making scans from even legacy systems clearer and more detailed.
  • Comprehensive Coverage: FDA-510K clearance ensures compatibility with all body parts, sequences, field strengths, and vendors.

SwiftMRTM

Our Mission

Since our establishment in 2010, we empower individuals with advanced, home-use photobiomodulation technology and foster scientific breakthroughs.

As the original inventors of home-use brain photobiomodulation technology, we lead with the most industry patents, ranging from AI to neuromodulation.

Our patented brain-systemic photobiomodulation technology has demonstrated efficacy in independent pilot and clinical trials for severe conditions.

Through our steadfast dedication to collaborative research with the brightest minds, our technology participates in the most published studies and ongoing clinical trials on a global scale.

We are certified as a medical device manufacturer under MDSAP and ISO 13485.

PhotoBioModulation

Grown From Innovation, Expertise and the Desire to Advance Patients and Customers

History – Our Milestones at a Glance

RAUMEDIC’s roots lie within the REHAU Group. Since the company’s foundation in 1948 we have been developing sophisticated products in collaboration with our customers. During that period of time we have learnt to recognize the real values. It is only through sustainable growth and an uncompromising quality philosophy towards customers and patients that consistently convincing results can be achieved. Upon our spin-off in 2004, we established RAUMEDIC as an independent medical-technology company. With a view to sustainable growth, we can be proud of what we have achieved so far. We will always feel a great pleasure, when our achievements contribute to the recovery of patients’ health, each and every day!  

More Info

Surgically Targeted Radiation Therapy (STaRT) for Brain Tumors

Tough on the tumor. Easier on you and your caregivers.

A radiation treatment specifically designed for use inside the brain, GammaTile Therapy gives patients new hope in the fight against brain tumors. It can eliminate the need for traditional repeat radiation treatments and associated hospital or clinic visits, so patients can focus on what matters most—healing.

Am I a candidate for GammaTile Therapy?

The highest resolution optics available for supermicro and plastic surgery.

The larger objective lens of the MM51 combined with Mitaka’s advanced 8:1 zoom system creates a microscope with twice the resolution and magnification of other surgical microscopes.

More Products

Synaptive Medical

Visible Innovation for Better Care

 

Synaptive Medical is a global Med Tech and technology company solving surgical, imaging and data challenges to improve the quality of human lives. 

 

We unite MRI, surgical planning and navigation, robotic automation, digital microscopy and informatics solutions to support neuro, spine, ENT and plastics/reconstructive procedures with the aim of helping you see patients in ways you never have before.

Our Portfolio:

Designed through interdisciplinary collaboration to support healthcare professionals and systems, the Synaptive product portfolio enables precision care through the synergy of high-quality information and cutting-edge automation at all stages of clinical intervention.

 

  • Synaptive MRI: Our mid-field, helium free, 0.5T head-only MRI offers flexible placement with a small footprint and premium image quality.
  • Modus Plan: Access patient-specific tractography with unprecedented ease, automatically segmented using AI and available in seconds.
  • Modus Navigation: Accurate navigation incorporating dynamic tractography to enable accurate execution of planned approaches.
  • Modus X: The industry leading robotic exoscope featuring advanced 4k 3D optics and fluorescence visualization.

 

Our product portfolio offers novel patient insights with automation and simplicity, from a tractography model produced within seconds to the leading robotic exoscope on the market providing surgical visualization with unparalleled clarity and precision, to a one-button-push MRI; all helping you to focus on your patient.

 

Redefining Precision in Surgical and Imaging Visualization – welcome to Synaptive Medical.

See More

The Next Evolution In Cellular Medicine

Celularity’s innovative approach harnesses the unique therapeutic potential locked within the cells and biomaterials of the postpartum placenta. We have multiple cell therapy candidates in active clinical development as well as a broad range of placental-derived biomaterial products for therapeutic use.

See More

Mission

The primary purpose of the Massoudi Foundation is to identify and provide financial support for promising scientific research designed to advance the understanding of human disease processes, particularly research that can lead to the development of safe and effective therapeutic interventions in the disorders of the mind and body.

See More

Surgically Targeted Radiation Therapy (STaRT) for Brain Tumors

About this book

Nanoneuroscience, nanoneurosurgery, and nanobioelectronics have the potential to revolutionize medicine and improve the prevention, diagnosis, and treatment of neurological disorders over the next 10-20 years. The Textbook of Nanoneuroscience and Nanoneurosurgery, 2nd edition presents a state-of-the-art review of the field, providing current information about nanoplatforms and their use in neurosurgery, neurology, neuroscience, and neuroradiology.

This volume describes advances that have already been translated to the clinic or hold significant promise for future application in nanoneurosurgery, as well as their potential impact. A full-color text, the book contains contributions by more than 120 researchers, original and descriptive illustrations, and more than 3,000 references. Offering broad coverage of nanotechnological applications in diverse areas and addressing FDA regulation and healthcare policy, this volume provides a foundation of ideas and methods for scientists and physicians to devise successful, less invasive procedures for future treatment of nervous system disorders.[km1]

More On this Book

Empowering researchers to accelerate progress in science and medicine by leading a transformation in research communication.

The Journal of Alzheimer’s Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease. The journal publishes research reports, reviews, systematic reviews, short communications, hypotheses, commentaries, editorials, ethics reviews/responses, and book reviews.

Impact Factor/H-Factor

JAD has an Impact Factor of 4.0 [2022 Journal Citation Reports (Source: Clarivate, 2023)], an h-index of 149 (Web of Science), an h-index of 163 (SCImago Journal Rank indicator), a CiteScore of 6.4 (Scopus), an h5-index of 88 (Google Scholar), and an h5-median of 138 (Google Scholar).

Current Issue

Who We Are

For doctors who want to thrive in the digital age by managing their pipeline of new patient acquisition by understanding their data and maximizing marketing budget.

Let Us Grow Your Practice

Our Media Partners SBMT 2024

Disclaimer: The logos, pictures, trademarks, and/or likenesses used in this marketing material are the exclusive property of their respective owners. These elements are included solely for informational and illustrative purposes to demonstrate the participation of these companies in our conference. No claim of ownership or affiliation is made by the SBMT, its initiatives, or affiliates, and no endorsement or sponsorship is implied by their inclusion. Additionally, no claim is made, implied, or explicit to the exclusive right to use any such logos by the SBMT, its initiatives, and affiliates.